Oxidative stress and vascular damage in hypertension

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 2, 2001, Pages 247-255

  Berry, Colin ^a   Brosnan, M Julia ^a   Fennell, Jerome ^a   Hamilton, Carlene A ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; DISEASE ASSOCIATION; ENZYME ANALYSIS; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ESTROGENS; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION; MITOCHONDRIA; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NITRATES; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; VITAMINS; XANTHINE OXIDASE;

EID: 0035107273     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200103000-00014     Document Type: Article

References (91)

1. Sick vessel syndrome: Can atherosclerotic arteries recover?
2. NADH oxidoreductase is a major source of superoxide anion in bovine coronary-artery endothelium
3. Hypercholesterolemia increases endothelial superoxide anion production
4. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension
5. Superoxide anion production is increased in a model of genetic hypertension - Role of the endothelium
6. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis
7. Paracrine role of adventitial superoxide anion in spontaneous tone in the isolated rat aorta in angiotensin II-induced hypertension
8. Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD
9. Enzymatic mechanisms of superoxide production
10. NADH oxidase of plasma-membranes
11. NADPH oxidase: An update
12. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets
13. Making sense out of oxygen sensor
14. NAD(P)H oxidase - Role in cardiovascular biology and disease
15. P22(phox) is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
16. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II
17. Cell transformation by the superoxide-generating oxidase Mox1
18. Xanthine oxidoreductase
19. Oxygen-derived free-radicals in postischemic tissue-injury
20. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase
21. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury
22. Superoxide generation from endothelial nitric-oxide synthase-a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process
23. Generation of superoxide by purified brain nitric-oxide synthase
24. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
25. Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential
26. Interactions of oxidants with vascular signaling systems
27. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells
28. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage
29. Lack of tyrosine nitration by peroxynitrite generated at physiological pH
30. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite
31. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium
32. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1
33. Transcriptional and post-transcriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide
34. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats
35. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation-contribution to alterations of vasomotor tone
36. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt
37. Reduced vascular myocyte relaxation to sodium nitroprusside in DOCA-salt hypertensive rats
38. A mechanism of oxygen free radical production in the Dahl hypertensive rat
39. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
40. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide
41. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro-implications for atherosclerotic plaque stability
42. 2- in vascular smooth-muscle cells
43. Vascular cell-adhesion molecule-1 (VCAM-1) gene-transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial-cells
44. Oxidant signaling in vascular cell growth, death, and survival
45. PYK2/CAK beta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells
46. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II-involvement of p22phox and reactive oxygen species
47. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinases and activates Ras and extracellular signal-related protein kinase group of mitogen-activated protein kinases
48. NF-kappa B inhibition ameliorates angiotensin II-induced inflammatory damage in rats
49. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress
50. Role of superoxide in the depressed nitric-oxide production by the endothelium of genetically hypertensive rats
51. Does superoxide underlie the pathogenesis of hypertension
52. Oxygen-derived free-radicals, endothelium, and responsiveness of vascular smooth-muscle
53. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
54. Atherosclerosis impairs flow-mediated dilation of coronary-arteries in humans
55. Inhibition and stimulation of nitric-oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes
56. Effects of nitric oxide and superoxide on relaxation in human artery and vein
57. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries
58. Vascular superoxide production by NAD(P)H oxidase - Association with endothelial dysfunction and clinical risk factors
59. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis
60. Expression of NADH/NADPH oxidase p22(phox) in human coronary arteries
61. An investigation into the sources of superoxide production in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries
62. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo
63. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells
64. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease - Relation to endothelium-dependent vasodilation
65. Mechanisms of disease: The protective effects of estrogen on the cardiovascular system
66. 17 Beta-estradiol restores endothelial nitric oxide release to shear stress in arterioles of male hypertensive rats
67. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils
68. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived superoxide anion production
69. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
70. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome
71. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease
72. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial
73. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats
74. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
75. Lecithinized superoxide dismutase induces vasodilation: Evidence of direct contribution of superoxide anions to modulating vascular tone
76. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F-2 alpha
77. Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction
78. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP
79. Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium
80. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro
81. Renin-angiotensin system inhibition reduces free radical concentrations in arteries of patients with coronary heart disease
82. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF Study)
83. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease - The TREND (Trial on Reversing ENdothelial Dysfunction) Study
84. Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries
85. Effects of a hydroxylated metabolite of the beta-adrenoreceptor antagonist, carvedilol, on post-ischaemic splanchnic tissue injury
86. Nitric-oxide mediated venodilator effects of nebivolol
87. Nebivolol: A third-generation beta-blocker that augments vascular nitric oxide release endothelial beta(2)-adrenergic receptor-mediated nitric oxide production
88. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension
89. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol
90. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure